Literature DB >> 31262587

Potential use of microarray patches for vaccine delivery in low- and middle- income countries.

Nicolas Peyraud1, Darin Zehrung2, Courtney Jarrahian2, Collrane Frivold2, Toritse Orubu3, Birgitte Giersing4.   

Abstract

Microarray patches (MAPs), also referred to as microneedle patches, are a novel methodology that have the potential to overcome barriers to vaccine delivery in low- and middle-income countries (LMICs), and transform the way that vaccines are delivered within immunization programs. The World Health Organization's Initiative for Vaccine Research and its partners are working to understand how MAPs could ease vaccine delivery and increase equitable access to vaccines in LMICs. Global stakeholders have been engaged to evaluate technical, economic, and programmatic challenges; to validate assumptions where possible; and to propose areas of focus to facilitate future vaccine-MAP product development. This report summarizes those learnings.
Copyright © 2019 The Authors. Published by Elsevier Ltd.. All rights reserved.

Entities:  

Keywords:  Delivery; Microarray patches; Microneedle patches; Product development; Vaccine

Mesh:

Substances:

Year:  2019        PMID: 31262587     DOI: 10.1016/j.vaccine.2019.03.035

Source DB:  PubMed          Journal:  Vaccine        ISSN: 0264-410X            Impact factor:   3.641


  17 in total

Review 1.  The potential role of using vaccine patches to induce immunity: platform and pathways to innovation and commercialization.

Authors:  Kamran Badizadegan; James L Goodson; Paul A Rota; Kimberly M Thompson
Journal:  Expert Rev Vaccines       Date:  2020-03-17       Impact factor: 5.217

2.  Design of Dissolvable Microneedles for Delivery of a Pfs47-Based Malaria Transmission-Blocking Vaccine.

Authors:  Lampouguin Yenkoidiok-Douti; Carolina Barillas-Mury; Christopher M Jewell
Journal:  ACS Biomater Sci Eng       Date:  2021-02-22

3.  Human-centred design of a new microneedle-based hormonal contraceptive delivery system.

Authors:  Benedetta Gualeni; Louise Hughes; Isabelle Stauber; Louise Ackers; Angela Gorman; Dorothy Gashuga; Nettie Dzabala; Frider Chimimba; Ibrahim Chikowe; Sion A Coulman; James C Birchall
Journal:  Gates Open Res       Date:  2021-07-30

Review 4.  Emerging skin-targeted drug delivery strategies to engineer immunity: A focus on infectious diseases.

Authors:  Emrullah Korkmaz; Stephen C Balmert; Cara Donahue Carey; Geza Erdos; Louis D Falo
Journal:  Expert Opin Drug Deliv       Date:  2020-10-06       Impact factor: 8.129

5.  Global vaccine action plan lessons learned I: Recommendations for the next decade.

Authors:  Noni MacDonald; Ezzeddine Mohsni; Yagob Al-Mazrou; Jon Kim Andrus; Narendra Arora; Susan Elden; Marie-Yvette Madrid; Rebecca Martin; Amani Mahmoud Mustafa; Helen Rees; David Salisbury; Qinjian Zhao; Ian Jones; Christoph A Steffen; Joachim Hombach; Katherine L O'Brien; Alejandro Cravioto
Journal:  Vaccine       Date:  2020-05-05       Impact factor: 3.641

6.  Evaluation of the clinical impact of repeat application of hydrogel-forming microneedle array patches.

Authors:  Rehan Al-Kasasbeh; Aaron J Brady; Aaron J Courtenay; Eneko Larrañeta; Maelíosa T C McCrudden; Donal O'Kane; Stephen Liggett; Ryan F Donnelly
Journal:  Drug Deliv Transl Res       Date:  2020-06       Impact factor: 4.617

Review 7.  A microneedle patch for measles and rubella vaccination: a game changer for achieving elimination.

Authors:  Mark R Prausnitz; James L Goodson; Paul A Rota; Walter A Orenstein
Journal:  Curr Opin Virol       Date:  2020-07-01       Impact factor: 7.090

8.  Progress in microneedle array patch (MAP) for vaccine delivery.

Authors:  Thuy Trang Nguyen; Yujeong Oh; Yunseo Kim; Yura Shin; Seung-Ki Baek; Jung-Hwan Park
Journal:  Hum Vaccin Immunother       Date:  2020-07-15       Impact factor: 3.452

Review 9.  Microarray patches enable the development of skin-targeted vaccines against COVID-19.

Authors:  Emrullah Korkmaz; Stephen C Balmert; Tina L Sumpter; Cara Donahue Carey; Geza Erdos; Louis D Falo
Journal:  Adv Drug Deliv Rev       Date:  2021-02-02       Impact factor: 17.873

10.  Vaccines for a healthy future: 21st DCVMN Annual General Meeting 2020 report.

Authors:  Sonia Pagliusi; Benoit Hayman; Stephen Jarrett
Journal:  Vaccine       Date:  2021-04-07       Impact factor: 3.641

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.